Status:
COMPLETED
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Lead Sponsor:
Gilead Sciences
Conditions:
Hepatitis C, Chronic
Eligibility:
All Genders
18+ years
Brief Summary
This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a pre...
Eligibility Criteria
Inclusion
- Key
- Have previously participated in a Gilead-sponsored hepatitis C study and received at least one Gilead OAV
- Have failed to achieve an SVR in a previous Gilead-sponsored study, as defined in the original treatment protocol
- Provide written, informed consent
- Be willing and able to comply with the visit schedule
- Key
Exclusion
- Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the follow-up Registry
- History of clinically significant illness or any other major medical disorder that may interfere with follow-up, assessments or compliance with the protocol
- Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Key Trial Info
Start Date :
December 19 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 9 2018
Estimated Enrollment :
570 Patients enrolled
Trial Details
Trial ID
NCT01457768
Start Date
December 19 2011
End Date
April 9 2018
Last Update
May 4 2018
Active Locations (323)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham Gastroenterology Associates
Birmingham, Alabama, United States, 35209
2
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
3
Digestive Health Specialists
Dothan, Alabama, United States, 36305
4
Mayo Clinic
Phoenix, Arizona, United States